TSX News -
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
55% of BriaCell patients1remained alive one year since enrollment in BriaCell’s Phase 2 study, markedly exceeding the survival rate of […]